News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter

Clinical - Pre-Clinical
CTI BioPharma Presents Nonclinical Pharmacology Study Demonstrating Pacritinib Has Distinct Profile Amongst JAK Inhibitors At European Organization for Research and Treatment of Cancer-NCI-AACR Molecular Targets And Cancer Therapeutics Symposium 12/2/2016
Surface Oncology CD47 Program Demonstrates Promising Anti-Tumor Activity In Hematological Disease Models 12/2/2016
Kura Oncology Presents Preclinical Data On KO-947 And Menin-MLL Inhibitor Program At The EORTC-NCI-AACR Symposium On Molecular Targets And Cancer Therapeutics 12/1/2016
A1M Pharma Has Successfully Conducted Preclinical Toxicology/Safety Studies Within Preeclampsia 12/1/2016
VAXIMM Presents Preclinical Data On Three Novel Oral T-Cell Cancer Immunotherapies At EORTC-NCI-AACR Symposium 12/1/2016
Axial Biotherapeutics Announces The Groundbreaking Discovery Of A Biological Link Between The Gut Microbiome And Parkinson’s Disease Published In Cell 12/1/2016
Pharmazz Advances Its Product Pipeline For The Treatment Of Stroke, Strengthens Patent Portfolio And Presents Hemorrhagic Shock Data At The AHA 11/30/2016
X4 Pharma Announces New Data For Lead Candidate X4P-001 In Renal Cell Carcinoma At EORTC-NCI-AACR Molecular Targets And Cancer Therapeutics Symposium 11/30/2016
Cyteir Therapeutics Presents Preclinical Data On Use Of DNA Repair Modulators For Lymphoid Malignancies At American Society of Hematology Annual Meeting 11/29/2016
Ignyta (RXDX) To Debut Preclinical Data On RXDX-106 At The 2016 EORTC-NCI-AACR Annual Meeting 11/29/2016
PhaseRx (PZRX) Receives Orphan Drug Designation From FDA For PRX-OTC For The Treatment Of Ornithine Transcarbamylase Deficiency 11/28/2016
Portola (PTLA) Announces Andexxa™ (Andexanet Alfa), Betrixaban And Cerdulatinib Data To Be Presented At 2016 American Society of Hematology Annual Meeting And Exposition 11/28/2016
AiCuris Announces U.S. NIH Support Of Preclinical Study With AIC649 Against Chronic Hepatitis B 11/23/2016
Novartis AG (NVS) and Google (GOOG)’s Verily Miss Smart Contact Lens Human Trial Goal 11/22/2016
Baxter International (BAX) Presented Exploratory Research On The Removal Of Inflammation-Related Molecules During Extracorporeal Blood Purification Therapy 11/22/2016
Chimerix (CMRX) Presents Data From A Preclinical Study Of Intravenous Brincidofovir At AAPS 11/18/2016
Momenta (MNTA) Announces Publication On The Design Of M230, A Novel Autoimmune Disease Drug Candidate, In Science Translational Medicine 11/17/2016
Probiodrug AG Release: Amyloid-beta (Abeta) Aggregate-Clearing By The Murine Anti-Pyroglutamate-3 Abeta IgG2a Monoclonal Antibody PBD-C06 With And Without A Complement Mutation In An Alzheimer’s Mouse Model 11/16/2016
New Pre-Clinical Data On A vTv Therapeutics (VTVT) Small Molecule Drug Candidate Against Parkinson’s Disease To Be Presented At The Society For Neuroscience 2016 Meeting In San Diego 11/16/2016
Arbutus Biopharma (ABUS) Presents HBV Drug Combination Studies At American Association for Study of Liver Diseases 11/15/2016
Marinus Pharma (MRNS) Release: Ganaxolone and Diazepam Administered Intravenously Synergistically Block Seizures In Animal Model Of Status Epilepticus 11/15/2016
Nanobiotix Presents NBTXR3 Preclinical Data Demonstrating Its Potential Usage As In Situ Vaccine For Cancer At The Society For Immunotherapy Of Cancer Annual Meeting 11/15/2016
Nativis, Inc. Announces Promising In Vitro Data From Ultra-Low Radio Frequency Energy (ulRFE) Study 11/15/2016
New Study Demonstrates Anti-Tumor Advantages For Combination Treatment Featuring Peregrine (PPHM)’ PS-Targeting Antibodies In A Preclinical Melanoma Model 11/14/2016
CEL-SCI (CVM) Reports Preclinical Data Showing LEAPS Vaccine Is Successful In Treating Rheumatoid Arthritis 11/14/2016
Celldex (CLDX) Presents Data On New Product Candidate, CDX-1140, A Novel CD40 Agonist Antibody 11/14/2016
Heat Biologics Presents Compact Preclinical Data At The Society For Immunotherapy Of Cancer Annual Meeting 11/14/2016
Nanobiotix Presents NBTXR3 Preclinical Data Demonstrating Its Potential Usage As In Situ Vaccine For Cancer At The Society For Immunotherapy Of Cancer Annual Meeting 11/14/2016
Samumed Presents Data For A Small Molecule Modulator Of Wnt Pathway As A Potential Topical Treatment For Chronic Tendinopathy 11/14/2016
Prometheus BioScience Inc. Provides Update On Hepastem NASH-Fibrosis Program With Late-Breaking Preclinical Data At 2016 American Association for Study of Liver Diseases Meeting 11/14/2016
Ignyta (RXDX) Announces Six Upcoming Presentations At The 2016 EORTC-NCI-AACR Annual Meeting 11/14/2016
Biothera Preclinical Data Further Validate Mechanism Of Its Phase II Cancer Immunotherapy, Imprime PGG 11/11/2016
Compugen Ltd. (CGEN) Immune Checkpoint Program Demonstrates Potential For Development Of New Cancer Immunotherapy Treatments 11/11/2016
Pulse Biosciences Announces New Data That Reinforce Potential Immuno-Oncology Benefits Of Nano-Pulse Stimulation Technology 11/11/2016
Atreca Presents Promising Findings From Lead Antibody Program At Society For Immunotherapy Of Cancer (SITC) Annual Meeting 11/11/2016
Inovio Pharma (INO) Zika Vaccine Protects Animals From Infection, Brain Damage And Death 11/10/2016
Single Dose Of Omeros (OMER)’ Lead MASP-3 Inhibitor OMS906 Shows Multi-Week Blockade Of The Alternative Pathway 11/10/2016
Discovery Of Cerecor Drug Candidate CERC-611 (LY3130481) Published In Nature Medicine 11/9/2016
Stanford University Researchers Use CRISPR to Repair Gene That Cause Sickle Cell, Human Trials Planned 11/8/2016
GlycoMimetics, Inc. (GLYC) To Present Preclinical Cancer Results At Society For Immunotherapy Of Cancer Meeting 11/8/2016
Windtree Therapeutics (WINT) Preclinical Study Results Show Potential For KL4 Surfactant As Possible Medical Countermeasure To Radiation Exposure 11/4/2016
Onxeo Announces Promising Results From Preclinical Studies Of Livatag In Pancreatic Cancer 11/4/2016
Spyryx Biosciences Presents Data At NACFC On SPX-101 Demonstrating Efficacy, Safety, And Stability In Animal Models 11/2/2016
NeuroVive (NVP) Reports Positive Pre-Clinical Results In NASH 11/1/2016
Study To Be Presented At NASS 2016 Evaluating Bone In-Growth For Stryker (SYK)’s 3D-Printed Tritanium PL Cage 10/28/2016
Onxeo Announces Promising Results From Preclinical Study Of Beleodaq Combination With Checkpoint Inhibitors 10/27/2016
Catabasis (CATB) Presents Positive Data For CAT-5571, A Novel Activator Of Autophagy, As A Potential Oral Treatment For Cystic Fibrosis At The 30th Annual North American Cystic Fibrosis Conference 10/27/2016
Allen Institute for Brain Science Announces Mapping Of The Mouse Cortex In 3D 10/27/2016
Biocryst (BCRX) Announces Late Breaker Presentation Of Galidesivir (BCX4430) Nonclinical Results In Zika Virus Infection At IDWeek 2016 10/27/2016
Synedgen Reports Promising Data Demonstrating Biofilm Disruption And Potentiation Of Antibacterial Activity In Burkholderia Clinical Isolates Treated With Glycopolymer-Based Therapeutics 10/27/2016
Synedgen Announces Presentation Of Data At NACFC Demonstrating Prevention Of Gastrointestinal Complications With Glycopolymer-Based Therapeutics In A Preclinical Model Of Cystic Fibrosis 10/27/2016
BioPharmX Studies Suggest Its Violet Iodine Formulation Inhibits Growth Of Both FBC And Common Breast Cancer Cells In Vitro 10/26/2016
Moleculin Announces Advancement Of Preclinical Testing For Brain Tumor Drug WP1122 10/26/2016
Ariad (ARIA) Announces Publication Of The Preclinical Profile Of Brigatinib In The Journal Clinical Cancer Research 10/26/2016
Preclinical Research Demonstrates Peregrine (PPHM)’ PS-Targeting Antibodies Enhance The Anti-Tumor Activity Of PD-L1 Checkpoint Inhibitors In Model Of Triple Negative Breast Cancer (TNBC) 10/24/2016
Spring Bank Pharmaceuticals, Inc. Presents Data On STING Agonist SB 11285 At The AACR Special Conference On Tumor Immunology And Immunotherapy 10/20/2016
SAGE Therapeutics (SAGE) And Collaborators Publish New Pre-Clinical Data In Neuropharmacology Demonstrating A Novel Metabotropic Mechanism Of Sage 10/20/2016
Cantargia To Present New Data From Preclinical Studies With CAN04 In Non-Small Cell Lung Cancer 10/20/2016
Cynata's Technology Significant Efficacy In Preclinical Asthma Study 10/17/2016
Acorda (ACOR) Release: Data From Clinical And Preclinical Trials Of CVT-301 For Treatment Of OFF Periods In Parkinson's Disease Published In Science Translational Medicine 10/13/2016
Cellerant Therapeutics, Inc. Presents Preclinical Data Showing Promise Of A Novel Differentiated Target On Leukemic Stem Cells 10/11/2016
Organovo (ONVO) Introduces 3D Bioprinted Human Liver As Leading Therapeutic Tissue In Preclinical Development 10/5/2016
Innovus Pharma Initiates Pre-Clinical And Clinical Program Evaluating The Safety And Efficacy Of Vesele With Sildenafil (Viagra) 10/5/2016
Spotlight Innovation Launches Development Of STL-182 To Treat Spinal Muscular Atrophy 10/4/2016
Axsome (AXSM) Announces Publication Of Research Showing AXS-02 Inhibits Pain In Animal Model Of Complex Regional Pain Syndrome 10/4/2016
OSE Immunotherapeutics To Present The Preclinical Data Of Its New Checkpoint Inhibitor Effi-DEM On SIRP-a/CD47 Strategic Pathway At The 2016 Immune Checkpoint Inhibitors Conference 10/4/2016
Asana Medical's Preclinical Study Indicates Promising Solution To Treat Ulcerative Colitis 10/4/2016
CohBar Advances First-In-Class Mitochondria Based Therapeutic To IND-Enabling Activities 9/30/2016
Karyopharm (KPTI) Publishes Preclinical Data In Nature Demonstrating Selinexor’s Potential In KRAS-Mutant Non-Small Cell Lung Cancer (NSCLC) 9/29/2016
Karyopharm (KPTI) Publishes Preclinical And Phase 1 Clinical Data For Selinexor In Ovarian Cancer In Clinical Cancer Research Publication 9/28/2016
Infinity Pharma (INFI) Presents Initial Clinical And New Preclinical Data On IPI-549 At Second CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference 9/27/2016
MiNA Announces Presentation Of Pre-Clinical Data Supporting On-Target Mechanism Of Action Of Clinical Candidate MTL-CEBPA 9/27/2016
Peregrine (PPHM) Presents Preclinical Data Demonstrating PS-Targeting Antibodies Significantly Enhance The Anti-Tumor Activity Of Multiple Checkpoint Targeting Agents In Model Of Triple Negative Breast Cancer (TNBC) 9/27/2016
Viking Therapeutics (VKTX) Presents Positive Proof-Of-Concept Data For VK0214 In In Vivo Model Of X-Linked Adrenoleukodystrophy (X-ALD) At The 86th Annual Meeting Of The American Thyroid Association 9/26/2016
MabVax Therapeutics Humab-5B1 Based Diagnostic Imaging And Radioimmunotherapy Programs Featured At The 2016 World Molecular Imaging Congress 9/26/2016
Allakos Antibodies Shown To Inhibit Fibrosis, A Common Cause Of Organ Failure 9/26/2016
BerGenBio AS: New BGB324 Study Points To Novel Mechanism To Enhance Immunotherapy Efficacy 9/26/2016
Renova Therapeutics Release: The Journal Of Clinical Investigation Insight Publishes Preclinical Results Of Urocortin 2 Gene Transfer In Mouse Models Of Insulin Resistance 9/22/2016
Turing Announces Development Of New Drug Candidates For Toxoplasmosis 9/22/2016
Avacta Group Release: Positive Results From First Preclinical In-Vivo Studies Of Affimer Therapeutics 9/22/2016
Proteostasis (PTI) Announces Scientific Presentations On New Data At 30th Annual North American Cystic Fibrosis Conference 9/22/2016
Regen BioPharma Receives Positive Data From Preclinical Studies Of Its Small Molecule NR2F6 Modulators 9/20/2016
Sutro Biopharma ADCs Targeting CD74 Suppress Tumors In Multiple Malignant Cell Lines And Animal Models Of Multiple Myeloma And Non-Hodgkin Lymphoma 9/19/2016
Cephalogics Announces Results Of In Vivo Studies That Demonstrate The Ability Of Its Compact Perfusion Imaging System To Identify And Track Brain Perfusion Deficits 9/19/2016
Boston Children's Hospital Release: Antibiotic Gel Squirted Into The Ear Could Provide A One-Dose Cure For Ear Infections 9/15/2016
ArQule, Inc. (ARQL)Announces Publication Of Manuscript Highlighting Preclinical Activity Of FGFR Inhibitor, ARQ 087, In Peer Reviewed Journal 9/15/2016
Global Blood Therapeutics (GBT) Announces Publication Of Preclinical Results Supporting GBT440 Program For Hypoxemic Pulmonary Disorders 9/15/2016
Onxeo Announces First Outcomes Of Livatag Preclinical Plan 9/13/2016
Probiodrug AG Release: Combination Therapy With Glutaminyl Cyclase (QC) Inhibitor PQ912 And pGlu-Abeta Specific Antibody PBD-C06 Shows Clear Additive Effects In Reducing pGlu-Abeta As Well As Abeta In Alzheimer-Mouse Model 9/13/2016
ContraVir Reports New CRV431 Data Highlighting Synergistic Activity With CMX157 Against Hepatitis B 9/12/2016
Omeros (OMER)’ MASP-2 Antibody Preserves Brain Tissue And Function In Stroke Models 9/8/2016
Interferon Shows Promise As Flu Therapy, Francis Crick Institute in London Study 9/7/2016
Promising New Findings For Probiodrug AG's Glutaminyl Cyclase - Inhibitor In An Inflammation Animal Model 9/7/2016
Tarix Orphan Receives Orphan Drug Status For TXA127 For Genetic Skin Disorder Recessive Dystrophic Epidermolysis Bullosa (RDEB) 9/7/2016
Biocryst (BCRX) Announces Positive Study Results For BCX4430 Delayed Treatment Of Ebola Virus Infection In A Non-Human Primate Model 9/7/2016
Onxeo: Combination Of Asidna And PARP Inhibitors Demonstrates Synergistic Effect, Bypasses Genetic Restriction 9/7/2016
Cyclacel Pharma (CYCC)’s CYC065 Demonstrates Promising Activity In MYCN-Addicted Neuroblastoma In Preclinical Data Presented At Childhood Cancer 2016 9/6/2016
Can Pomegranates Protect The Brain From Dementia? University of New South Wales Reveals 9/1/2016
Biogen (BIIB)'s Experimental Alzheimer’s Drug Shows Promise in Human Trials 9/1/2016
Researchers Target Gut Bacteria To Reduce Weight Gain, Vanderbilt University Study 8/29/2016
European Society of Cardiology Congress Poster Session Reveals Results From Pre-Clinical Study Using CardioCell's Stem Cells for Chronic Ischemic Cardiomyopathy 8/29/2016
European Society of Cardiology Congress Presentation Reveals Results From Pre-Clinical Study Using CardioCell's Stem Cells For Acute Myocardial Infarction (AMI) 8/29/2016
Vybion, Inc. Release: Novel Gene Therapy Drug For Huntington's Disease 8/24/2016
US Phytotherapy Reports Successful Pre-Clinical Testing Of PROACT-D 8/24/2016
Idera Pharma (IDRA) Presents The Novel Mechanism Of Action Of Its Third Generation Antisense Technology 8/24/2016
NYU Langone Medical Center Release: Antibiotic Treatment Increased Risk For Type 1 Diabetes In Animal Study 8/22/2016
DeuteRx Enters Clinical Stage Development With DRX-065 8/22/2016
Regeneron (REGN) Announces Agreement With BARDA For The Manufacturing And Testing Of New Antibodies Against MERS Virus 8/22/2016
ContraVir To Release New CRV431 Data Highlighting Potential Synergy With CMX157 Against Hepatitis B 8/22/2016
iX Biopharma Announces Development Of Supplement For Jet Lag 8/17/2016
GlycoMimetics, Inc. (GLYC) Announces Publication Of Preclinical Data Showing Drug Candidate GMI-1271 Reduces Inflammatory Responses After Heart Attack 8/16/2016
Basilea (BSLN.SW) Ends Further Development of Inhaled Antibiotic BAL30072 8/15/2016
Tissue Regeneration Therapeutics Inc. Engineered Mesenchymal Stromal Cells Advance Monoclonal Antibody Therapy 8/15/2016
Novogen Limited (NVGN) Submits Investigational New Drug (IND) Application To The US FDA For Cantrixil In Ovarian Cancer 8/11/2016
Veritas Pharma Inc Reaches Important Scientific Milestone; Animal Studies Fully Underway To Evaluate The Safety And Effectiveness Of Cannabis Strains 8/10/2016
iX Biopharma Is Developing Its Next Drug In Pain Management 8/10/2016
Oregon State University Release: Walnuts A Key Food To Improve Metabolism In Obese Mice 8/9/2016
Phytecs Expands Research Slate; Preclinical Data Indicates Its Fluorinated CBD Exhibits Greater Potency Than CBD In Models Of Psychiatric Disorders 8/9/2016
REGENXBIO's Gene Therapy for Hunter Syndrome Nabs FDA's 'Rare Pediatric Disease' Status 8/2/2016
Cyclacel Pharmaceuticals, Inc. (CYCC)’s CYC065 Demonstrates Promising Activity In Uterine Serous Carcinoma In Preclinical Data Published By Independent Academic Researchers 8/2/2016
Addex Therapeutics (ADXN.SW) ADX71441 Demonstrates Positive Results In Highly Translational Preclinical Model Of Spasticity 7/27/2016
Viking Therapeutics (VKTX) Announces Positive Top-Line Results From Proof-Of-Concept Study Of VK0214 In In Vivo Model Of X-Linked Adrenoleukodystrophy (X-ALD) 7/26/2016
Sangamo (SGMO) Announces New Gene Therapy Clinical Development Program for Treatment Of Hemophilia A 7/26/2016
Elusys Therapeutics, Inc. Announces That Manuscripts For Its Anthrax Antitoxin, ANTHIM (Obiltoxaximab) Injection, Have Been Accepted For Publication 7/20/2016
Synaffix Achieves Significantly Improved Therapeutic Index Compared To Both FDA-Approved ADCS And Expands Its Scientific Advisory Board 7/20/2016
MedImmune (AZN) Release: New CELL Study Presents Groundbreaking Pre-Clinical Work: Developing Immune Therapy To Potentially Treat Serious Influenza A 7/20/2016
Alcobra (ADHD) Granted European Orphan Drug Designation For Metadoxine In Fragile X Syndrome 7/19/2016
YiSheng BioPharma And The United States Army Medical Research Institute Of Infectious Diseases Announce Positive Animal Results Of Vaccine Against Ebola Virus 7/14/2016
Inovio Biomedical Corporation Deploys DNA-Based Monoclonal Antibody Technology In Quest To Cure HIV 7/14/2016
Matinas BioPharma Announces Presentation Of Cryptococcal Meningitis Preclinical Data Of MAT2203 At AIDS-Associated Mycosis Meeting 2016 7/13/2016
Fangyuan Pharma Plans Trials Of New-To-China Antibiotic 7/13/2016
Organovo (ONVO) And Roche (RHHBY) Researchers Publish Data Demonstrating Superiority Of 3D Bioprinted Human Liver Tissues In Assessing Drug-Induced Toxicity 7/11/2016
Global Blood Therapeutics (GBT) Announces Publication Of Preclinical GBT440 Results In British Journal Of Haematology That Support Sickle Cell Disease (SCD) Program 7/8/2016
Preclinical Study Validates Science Behind AlloSource's AlloStem Cellular Bone Allograft 7/7/2016
Heat Biologics Announces “Cancer Immunology Research” Publication Featuring Its Compact Platform Technology 7/7/2016
Verastem (VSTM) Release: Study Published In Nature Medicine Highlights Potential Role Of FAK Inhibition In Pancreatic Cancer 7/5/2016
Biocryst (BCRX) Receives Additional NIAID Funding To Advance Development Of BCX4430 To Treat Hemorrhagic Fever Virus Diseases 7/5/2016
Strekin AG Announces The Presentation Of Key STR001 Data At The Conference On Molecular Biology Of Hearing And Deafness, Cambridge UK 7/1/2016
New Preclinical Data Show Potential Of Dicerna (DRNA) GalXC Subcutaneous Delivery Platform As RNAi Drug Discovery Engine 6/29/2016
Immune Pharma Release: New Data Suggests Improved Tumor Response For The Combination of AZIXA and Immune Checkpoint Inhibitors in The Treatment of Cancer 6/28/2016
Entasis Presents Data Supporting The Potential Clinical Utility Of ETX2514, A Next-generation Beta-lactamase Inhibitor, At ASM Microbe 2016 6/28/2016
Tarix Orphan Announces Positive Results With TXA127 In Animal Model Of Dystrophic Epidermolysis Bullosa (DEB) 6/27/2016
PAVmed (PAVMU) Successfully Completes CarpX Pre-Clinical Study 6/24/2016
NYU Langone Medical Center Release: Compound Shown To Reduce Brain Damage Caused By Anesthesia In Animal Model 6/23/2016
Cerulean Pharma Inc. (CERU) Announces Publication In Cancer Research 6/22/2016
Compugen Ltd. (CGEN) Discloses Lead Therapeutic Candidate For CGEN-15029 Immuno-Oncology Program 6/22/2016
A1M Pharma Select Research Toxicology Centre For Preclinical Toxicology Studies On RMC-035 Novel Pre-Eclampsia Drug 6/22/2016
Inovio Pharma (INO)'s DNA Vaccine For Zika Virus Induces Robust Immune Responses In Preclinical Study 6/22/2016
Dipexium Pharmaceuticals (DPRX)' Locilex Microbiology Data Presented At American Society for Microbiology Microbe 2016 Conference 6/21/2016
Seres Therapeutics Presents New Data At American Society for Microbiology Microbe 2016, Including Characterization Of SER-262, The Rationally-Designed, Fermented Microbiome Therapeutic Candidate For Primary Clostridium Difficile Infection 6/21/2016
Gilead (GILD) Presents Preliminary Data On Bictegravir, An Investigational Integrase Strand Transfer Inhibitor For The Treatment Of HIV 6/20/2016
NEMUS Bioscience Announces Enhanced Ocular Tissue Concentration By The Proprietary Prodrug Of Tetrahydrocannabinol (NB1111) - Associated With A Superior Decline In Intra-Ocular Pressure (IOP) In An Animal Model 6/17/2016
Exemplar Genetics To Present On Novel Research Models For Oncology At The World Preclinical Congress 6/16/2016
Therapix Filed An Application With The FDA To Approve An "Orphan" Designation For The Drug Developed Based On The Entourage Technology For Treating Tourette's Syndrome 6/15/2016
twoXAR Completes Initial Studies Of New Rheumatoid Arthritis Drug Candidates 6/14/2016
VeroScience Is Pleased To Support Independent Research From The Laboratory Of Dr. Defronzo And Team At UT Health Science Center, San Antonio 6/13/2016
DBV Tech Announces Publication Of Preclinical Data In JACI Suggesting EPIT Provides Sustained Protection Against Anaphylaxis 6/13/2016
Cytori Therapeutics (CYTX) Cell Therapy Leads To Improved Function And Reduced Scar Tissue In A Urinary Injury Model 6/10/2016
AMO Pharma Presents Pre-Clinical Data Showing AMO-01 Successfully Inhibits Activated Pathway Associated With Fragile X Syndrome 6/7/2016
ASCO2016: Nektar Therapeutics (NKTR) Release: Preclinical Data Presented At ASCO 2016 Annual Meeting Demonstrate That Single-Agent NKTR-214 Produces A Large Increase In Tumor-Infiltrating Lymphocytes To Provide Durable Anti-Tumor Activity 6/7/2016
Alzeca Biosciences’ ADx Imaging Technology Shows Positive Results in Early Detection Of Alzheimer's 6/7/2016
Novavax (NVAX) Announces New Seasonal Combination Respiratory Vaccine Program 6/3/2016
ASCO2016: Acetylon Pharmaceuticals Collaborators Publish ASCO Abstracts Demonstrating Immunomodulatory Properties Of Ricolinostat In Preclinical Melanoma Models 6/3/2016
Biotech Holdings Ltd. (BIOHF) Announces Positive Preclinical Results On ProCell Probiotic Cell Therapy For Critical Limb Ischemia 6/2/2016
Onxeo Announces Development Of Beleodaq Oral Formulation Opening New Opportunities For Its HDAC Inhibitor 6/2/2016
Vium Closes Technology Gap In Preclinical Research To Accelerate Drug Development 6/2/2016
ChromaDex, Inc. Release: University Researchers Show Vitamin Nicotinamide Riboside Is An Effective Tool For Managing The Negative Effects Of Obesity And Diabetes 6/1/2016
BioSpecifics Technologies Corporation (BSTC) Announces Publication Of Encouraging Data For Uterine Fibroid Treatment With CCH In American Journal Of Obstetrics & Gynecology 5/31/2016
Nanobiotix Establishes Promising Preclinical Proof-Of-Concept In Immuno Oncology 5/31/2016
Shenyang Research Institute Selects Provantis Preclinical Software Solution For Chinese Drug Safety Evaluation Center 5/26/2016
GlycoMimetics, Inc. (GLYC) Announces Publication Of New Preclinical Data With GMI-1271 In Science Translational Medicine 5/26/2016
Viamet Receives Orphan Drug Designation From The FDA For VT-1598 For The Treatment Of Coccidioidomycosis 5/25/2016
Reviva Pharma Presented RP5063 Preclinical Efficacy Results For Pulmonary Arterial Hypertension At American Thoracic Society Conference 2016 5/20/2016
Regen BioPharma Announces ucVax: Universal Donor Cancer Cellular Immunotherapy 5/19/2016
Anavex (AVXL) Announces Positive Preclinical Data For ANAVEX 2-73 In Infantile Spasms 5/18/2016
Fate Therapeutics (FATE) Announces Preclinical Data Highlighting Persistent Effector Function Of Allogeneic Natural Killer Cell Cancer Immunotherapy 5/16/2016
TopiVert Completes TOP1630 Preclinical Development 5/16/2016
NovoCure To Present New Preclinical Data Showing Additive Efficacy Of Tumor Treating Fields And PD-1 Inhibitors At The American Association Of Immunologists’ Annual Meeting 2016 5/13/2016
Biostage Successfully Regenerates Esophagus In Groundbreaking Pre-Clinical Work With Mayo Clinic; Data Provides 'Proof Of Concept' To Seek FDA Approval For Clinical Trials 5/12/2016
Dicerna (DRNA) Reports Potent Preclinical Activity With GalNAc-DsiRNA-EX Conjugates 5/11/2016
IIT Research Institute Release: Zika Mouse Model Using Current Strain Enhances Quest For New Vaccines And Treatments 5/10/2016
IIT Research Institute Release: Zika Mouse Model Using Current Strain Enhances Quest For New Vaccines And Treatments 5/10/2016
Sangamo (SGMO) Presents Recent Developments From Research And ZFP Therapeutic Programs In Multiple Presentations At Annual Meeting Of The American Society Of Gene And Cell Therapy 5/9/2016
Dimension Therapeutics Announces Preclinical Data From Bayer-Partnered Hemophilia A Program At American Society For Gene And Cell Therapy (ASGCT) Annual Meeting 5/9/2016
uniQure (QURE) Presents Preclinical Data On AAV Re-Administration, Regulated Gene Expression And Total Brain Transduction At ASGCT 5/9/2016
GTx, Inc. (GTXI) Announces Presentation Of Preclinical Data Demonstrating The Ability Of Sards To Degrade And Inhibit The Androgen Receptor At The American Urological Association Annual Meeting 5/9/2016
Cytori Therapeutics (CYTX) Reports Preliminary Preclinical Data Supporting Use Of Cytori Cell Therapy For Both The Prevention And Treatment Of Hypertrophic Scars 5/5/2016
Relmada Therapeutics Announces Results Of In Vivo Study Showing d-Methadone Has Antidepressant-like Effects 5/4/2016
Acetylon Pharmaceuticals Publishes New Mechanism For The Treatment Of Sickle Cell Disease/Beta-Thalassemia With Selective HDAC1/2 Inhibition In Plos One 5/4/2016
Can-Fite BioPharma (CFBI) To Present Data On Cf602 In The Treatment Of Erectile Dysfunction At American Urological Association's Annual Meeting 5/2/2016
Eleven Biotherapeutics (EBIO) To Present Data At The Association for Research in Vision & Ophthalmology 2016 Annual Meeting 4/29/2016
Exemplar Genetics Release: Game-Changing Animal Research Models Offer Superior Translational Research And Better Predictive Efficacy 4/27/2016
ThromboGenics NV (TBGNF) Release: New Ocriplasmin Research Findings Presented At Upcoming Association for Research in Vision & Ophthalmology 2016 Annual Meeting In Seattle 4/27/2016
Independent Rat Study Finds 54% Oral Insulin Relative Bioavailability Using Tamarisk's MxBA Platform Technology 4/26/2016
NeuroVive (NVP) Starts Preclinical TBI Program In Collaboration With University of Pennsylvania 4/26/2016
Arbutus Biopharma (ABUS) Presents Data From Combination Activity Studies Of HBV Drug Candidates 4/22/2016
Merrimack (MACK) Unveils Its Latest Antibody Directed Nanotherapeutic, MM-310, At The 2016 AACR Annual Meeting 4/21/2016
Affimed (AFMD) Presents Data On AFM13-Mediated Innate/Adaptive Immune Crosstalk At The AACR Annual Meeting 2016 4/21/2016
Affimed (AFMD) Presents Data On EGFRwt and EGFRvIII-Targeting NK- And T-Cell Tandabs At The AACR Annual Meeting 2016 4/21/2016
DelMar Pharma Release: FDA Grants Orphan Drug Designation For VAL-083 In Ovarian Cancer 4/21/2016